MILESTONE (MMD): Conclusion of the agreement with an Authorised Adviser - raport 13

The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”) informs that on May 16, 2016 the Issuer concluded an agreement with Navigator Capital S.A. with its registered office in Warsaw on rendering services of an Authorised Adviser to the Company. The subject of the agreement includes cooperation with the Company in fulfilling its disclosure obligations set out in the Alternative Trading System Rules and advising the Issuer in the scope of Company’s presence in Alternative Trading System on the NewConnect Market. The agreement becomes effective on the day of signing.

Legal basis: § 3 subparagraph 2 point 18 of the Exhibit 3 to the Alternative Trading System Rules "Current and Periodic Information in the Alternative System on the NewConnect Market".

Osoby reprezentujące spółkę:
Joseph D'Agostino - Chief Financial Officer